Literature DB >> 35973105

Early Stages of RNA-Mediated Conversion of Human Prions.

Emilia A Lubecka1, Ulrich H E Hansmann2.   

Abstract

Prion diseases are characterized by the conversion of prion proteins from a PrPC fold into a disease-causing PrPSC form that is self-replicating. A possible agent to trigger this conversion is polyadenosine RNA, but both mechanism and pathways of the conversion are poorly understood. Using coarse-grained molecular dynamic simulations we study the time evolution of PrPC over 600 μs. We find that both the D178N mutation and interacting with polyadenosine RNA reduce the helicity of the protein and encourage formation of segments with strand-like motifs. We conjecture that these transient β-strands nucleate the conversion of the protein to the scrapie conformation PrPSC.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35973105      PMCID: PMC9420815          DOI: 10.1021/acs.jpcb.2c04614

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   3.466


  47 in total

1.  AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.

Authors:  Oleg Trott; Arthur J Olson
Journal:  J Comput Chem       Date:  2010-01-30       Impact factor: 3.376

Review 2.  Mechanisms of prion-induced neurodegeneration.

Authors:  Paula Saá; David A Harris; Larisa Cervenakova
Journal:  Expert Rev Mol Med       Date:  2016-04-08       Impact factor: 5.600

3.  The I-TASSER Suite: protein structure and function prediction.

Authors:  Jianyi Yang; Renxiang Yan; Ambrish Roy; Dong Xu; Jonathan Poisson; Yang Zhang
Journal:  Nat Methods       Date:  2015-01       Impact factor: 28.547

4.  Dependence of the Formation of Tau and Aβ Peptide Mixed Aggregates on the Secondary Structure of the N-Terminal Region of Aβ.

Authors:  Ana V Rojas; Gia G Maisuradze; Harold A Scheraga
Journal:  J Phys Chem B       Date:  2018-07-10       Impact factor: 2.991

5.  Structural basis for the protective effect of the human prion protein carrying the dominant-negative E219K polymorphism.

Authors:  Ivana Biljan; Gabriele Giachin; Gregor Ilc; Igor Zhukov; Janez Plavec; Giuseppe Legname
Journal:  Biochem J       Date:  2012-09-01       Impact factor: 3.857

6.  Neurotoxicity of a prion protein fragment.

Authors:  G Forloni; N Angeretti; R Chiesa; E Monzani; M Salmona; O Bugiani; F Tagliavini
Journal:  Nature       Date:  1993-04-08       Impact factor: 49.962

7.  Calculation of protein backbone geometry from alpha-carbon coordinates based on peptide-group dipole alignment.

Authors:  A Liwo; M R Pincus; R J Wawak; S Rackovsky; H A Scheraga
Journal:  Protein Sci       Date:  1993-10       Impact factor: 6.725

8.  A new protein nucleic-acid coarse-grained force field based on the UNRES and NARES-2P force fields.

Authors:  Adam K Sieradzan; Artur Giełdoń; Yanping Yin; Yi He; Harold A Scheraga; Adam Liwo
Journal:  J Comput Chem       Date:  2018-10-11       Impact factor: 3.376

9.  Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures.

Authors:  David Sehnal; Sebastian Bittrich; Mandar Deshpande; Radka Svobodová; Karel Berka; Václav Bazgier; Sameer Velankar; Stephen K Burley; Jaroslav Koča; Alexander S Rose
Journal:  Nucleic Acids Res       Date:  2021-07-02       Impact factor: 16.971

10.  Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.

Authors:  Michael B Miller; James C Geoghegan; Surachai Supattapone
Journal:  PLoS Pathog       Date:  2011-07-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.